“…In the following year, after the implementation of a virtual tumor board, 60.3% of orders and 71.5% of claims were for HF RT. 22 These rates are lower than the ones that were observed by our study, which found 75.3% of orders in 2019 and 79.0% of orders in 2020 to be for HF RT.…”